69 related articles for article (PubMed ID: 31375085)
21. Antitumor effects of icaritin and the molecular mechanisms.
Zhang C; Sui X; Jiang Y; Wang X; Wang S
Discov Med; 2020; 29(156):5-16. PubMed ID: 32598859
[TBL] [Abstract][Full Text] [Related]
22. ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer.
Sugiura R; Satoh R; Takasaki T
Cells; 2021 Sep; 10(10):. PubMed ID: 34685488
[TBL] [Abstract][Full Text] [Related]
23. Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity.
Wang N; Fan Y; Yuan CM; Song J; Yao Y; Liu W; Gajendran B; Zacksenhaus E; Li Y; Liu J; Hao XJ; Ben-David Y
BMC Cancer; 2019 Aug; 19(1):764. PubMed ID: 31375085
[TBL] [Abstract][Full Text] [Related]
24. 1-Cinnamoyltrichilinin from
Jeong H; Park S; Kim SY; Cho SH; Jeong MS; Kim SR; Seo JB; Kim SH; Kim KN
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053881
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic and nitric oxide production-inhibitory activities of limonoids and other compounds from the leaves and bark of Melia azedarach.
Pan X; Matsumoto M; Nishimoto Y; Ogihara E; Zhang J; Ukiya M; Tokuda H; Koike K; Akihisa M; Akihisa T
Chem Biodivers; 2014 Aug; 11(8):1121-39. PubMed ID: 25146759
[TBL] [Abstract][Full Text] [Related]
26. New ring C-seco limonoids from Brazilian Melia azedarach and their cytotoxic activity.
Zhou H; Hamazaki A; Fontana JD; Takahashi H; Esumi T; Wandscheer CB; Tsujimoto H; Fukuyama Y
J Nat Prod; 2004 Sep; 67(9):1544-7. PubMed ID: 15387656
[TBL] [Abstract][Full Text] [Related]
27. Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2.
Heightman TD; Berdini V; Braithwaite H; Buck IM; Cassidy M; Castro J; Courtin A; Day JEH; East C; Fazal L; Graham B; Griffiths-Jones CM; Lyons JF; Martins V; Muench S; Munck JM; Norton D; O'Reilly M; Palmer N; Pathuri P; Reader M; Rees DC; Rich SJ; Richardson C; Saini H; Thompson NT; Wallis NG; Walton H; Wilsher NE; Woolford AJ; Cooke M; Cousin D; Onions S; Shannon J; Watts J; Murray CW
J Med Chem; 2018 Jun; 61(11):4978-4992. PubMed ID: 29775310
[TBL] [Abstract][Full Text] [Related]
28. Cancer statistics, 2018.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2018 Jan; 68(1):7-30. PubMed ID: 29313949
[TBL] [Abstract][Full Text] [Related]
29. Vanadium pentoxide increased PTEN and decreased SHP1 expression in NK-92MI cells, affecting PI3K-AKT-mTOR and Ras-MAPK pathways.
Gallardo-Vera F; Tapia-Rodriguez M; Diaz D; Fortoul van der Goes T; Montaño LF; Rendón-Huerta EP
J Immunotoxicol; 2018 Dec; 15(1):1-11. PubMed ID: 29228829
[TBL] [Abstract][Full Text] [Related]
30. Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib).
Germann UA; Furey BF; Markland W; Hoover RR; Aronov AM; Roix JJ; Hale M; Boucher DM; Sorrell DA; Martinez-Botella G; Fitzgibbon M; Shapiro P; Wick MJ; Samadani R; Meshaw K; Groover A; DeCrescenzo G; Namchuk M; Emery CM; Saha S; Welsch DJ
Mol Cancer Ther; 2017 Nov; 16(11):2351-2363. PubMed ID: 28939558
[TBL] [Abstract][Full Text] [Related]
31. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis.
Liu T; Yao Y; Zhang G; Wang Y; Deng B; Song J; Li X; Han F; Xiao X; Yang J; Xia L; Li YJ; Plachynta M; Zhang M; Yan C; Mu S; Luo H; Zacksenhaus E; Hao X; Ben-David Y
Oncotarget; 2017 Mar; 8(10):16728-16743. PubMed ID: 28052010
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic, antibacterial and antioxidant activities of extracts of the bark of Melia azedarach (China Berry).
Zahoor M; Ahmed M; Naz S; Ayaz M
Nat Prod Res; 2015; 29(12):1170-2. PubMed ID: 25426766
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Melia azedarach extracts against Streptococcus mutans.
Della Bona A; Nedel F
J Med Food; 2015 Feb; 18(2):259-63. PubMed ID: 25069066
[TBL] [Abstract][Full Text] [Related]
34. Bioactivity-guided chemical analysis of Melia azedarach L. (Meliaceae), displaying antidiabetic activity.
Khan MF; Rawat AK; Pawar B; Gautam S; Srivastava AK; Negi DS
Fitoterapia; 2014 Oct; 98():98-103. PubMed ID: 25062890
[TBL] [Abstract][Full Text] [Related]
35. Three new and other limonoids from the hexane extract of Melia azedarach fruits and their cytotoxic activities.
Pan X; Matsumoto M; Nakamura Y; Kikuchi T; Zhang J; Ukiya M; Suzuki T; Koike K; Akihisa R; Akihisa T
Chem Biodivers; 2014 Jul; 11(7):987-1000. PubMed ID: 25044585
[TBL] [Abstract][Full Text] [Related]
36. Secondary metabolites from the endophytic Botryosphaeria dothidea of Melia azedarach and their antifungal, antibacterial, antioxidant, and cytotoxic activities.
Xiao J; Zhang Q; Gao YQ; Tang JJ; Zhang AL; Gao JM
J Agric Food Chem; 2014 Apr; 62(16):3584-90. PubMed ID: 24689437
[TBL] [Abstract][Full Text] [Related]
37. Erythro-megakaryocytic transcription factors associated with hereditary anemia.
Crispino JD; Weiss MJ
Blood; 2014 May; 123(20):3080-8. PubMed ID: 24652993
[TBL] [Abstract][Full Text] [Related]
38. Effects of limonoid cedrelone on MDA-MB-231 breast tumor cells in vitro.
Fuzer AM; Filho JC; Becceneri AB; Dos Santos DA; da Silva MF; Vieira PC; Fernandes JB; Selistre-de-Araujo HS; Cazal CM; Cominetti MR
Anticancer Agents Med Chem; 2013 Dec; 13(10):1645-53. PubMed ID: 23869780
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
